EPISODE · Mar 15, 2024 · 8 MIN
Friday, March 15, 2024
from The Gist Healthcare Podcast
The federal government will investigate UnitedHealth Group following the Change Healthcare cyber attack. Diabetes and weight loss drug Ozempic was found to delay the progression of chronic kidney disease in diabetic patients, according to a large-scale clinical trial. And, drugmaker Eli Lilly partners with Amazon to deliver its weight loss drug Zepbound, directly to consumers’ homes. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
The federal government will investigate UnitedHealth Group following the Change Healthcare cyber attack. Diabetes and weight loss drug Ozempic was found to delay the progression of chronic kidney disease in diabetic patients, according to a large-scale clinical trial. And, drugmaker Eli Lilly partners with Amazon to deliver its weight loss drug Zepbound, directly to consumers’ homes. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Friday, March 15, 2024
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m